Contrive Datum Insights has published "Biotextiles Market Size, Share & Industry Analysis, By Type (Non-bioabsorbable, Bioabsorbable), Application (Hospital, Clinic), Product (Sutures, Surgical Meshes, Wound Care Dressings, Vascular Grafts, Others), Material (Synthetic Polymers, Natural Polymers), Structure (Nonwoven, Knitted, Woven), and Regional Forecast, 2026-2034". The study sizes the global biotextiles market at USD 54.8 billion in 2025 and projects growth from USD 60 billion in 2026 to USD 119.59 billion by 2034, a compound annual growth rate of 9% across the forecast period.
Biotextiles are fiber-based medical materials, woven, knitted or formed into nonwoven structures, that are engineered from synthetic or natural biopolymers for use inside or on the body. The category spans absorbable and non-absorbable sutures, surgical meshes, wound dressings and vascular grafts used to repair, support or replace soft tissue. Buyers are hospitals performing surgical and reconstructive procedures, outpatient clinics managing wound care, and the device manufacturers that convert raw biotextile fiber into finished implants.
Rising adoption of bioabsorbable implants in surgical procedures
Rising adoption of bioabsorbable implants in surgical procedures is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 9% a year, the type lines exposed to it move fastest: Bioabsorbable compounds at 11.59%, taking its share of revenue from 42% to 52% and its value from USD 23.02 billion to USD 62.19 billion.
A more favourable outcome is possible. If bull assumes faster clinical adoption of bioabsorbable and vascular-graft biotextiles, quicker regulatory clearance for new biopolymer formulations, and additional manufacturing capacity coming online in Asia Pacific ahead of schedule, 2034 revenue reaches USD 135.74 billion instead of the USD 119.59 billion the base case carries.
On the downside, bear assumes slower reimbursement support for higher-priced absorbable and vascular-graft products, extended regulatory review of new biopolymer formulations, and hospitals delaying the switch away from established non-absorbable materials, which would hold 2034 revenue to USD 106.67 billion. Non-bioabsorbable, which carries 58% of 2025 revenue, already grows at only 6.71% against the market's 9%, so the largest part of the base is also its slowest.
Key Players Compete on Non-bioabsorbable Volume and Bioabsorbable Growth
Two positions matter, and they are set by type. Non-bioabsorbable carries 58% of 2025 revenue (USD 31.78 billion) and is still the largest line in 2034 at 48%, hard to take from an incumbent. Bioabsorbable, at 11.59%, is where the USD 54.8 billion base is redistributed. The two demand different capabilities.
Other Findings in the Study
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Hospital | 72% · USD 39.46 billion | Clinic 11.44% |
| Product | Sutures | 30% · USD 16.44 billion | Vascular Grafts 13.47% |
| Material | Synthetic Polymers | 64% · USD 35.07 billion | Natural Polymers 10.93% |
| Structure | Nonwoven | 40% · USD 21.92 billion | — |
- North America was the largest region in 2025, holding 38% of global revenue at USD 20.82 billion and reaching USD 40.66 billion by 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 24% in 2025 to 30% in 2034, with revenue growing from USD 13.15 billion to USD 35.88 billion.
- At 4% of 2025 revenue and 4% by 2034, Middle East and Africa is the smallest region throughout.
- By type, the largest line in 2025 was Non-bioabsorbable, at 58% of revenue and USD 31.78 billion.
- Bioabsorbable is projected to grow at 11.59% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 17.49 billion in 2025, 31.92% of global revenue.
The report segments the market across five axes; by type, and by application, product, material and structure; with revenue and a growth rate for every line in every year from 2020 to 2034, alongside bear, base and bull scenarios for the headline total at USD 106.67 billion and USD 135.74 billion by 2034. It covers all five regions with country-level breakdowns, the competitive landscape, and the research methodology behind every estimate. Delivered as a PDF; a free sample is available on request.